Shanghai, China

Huchen Zhou

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 11.0

ph-index = 6

Forward Citations = 147(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Huchen Zhou in Anti-Inflammatory and Anti-Protozoal Treatments

Introduction

Huchen Zhou is a distinguished inventor based in Shanghai, China, renowned for his contributions to pharmaceutical innovations. With a notable portfolio of 9 patents, he has made significant strides in developing novel compounds for treating various medical conditions. His research primarily focuses on leveraging boron-containing small molecules for therapeutic applications.

Latest Patents

Among Huchen Zhou's most recent patents are two groundbreaking innovations. The first patent pertains to "Boron-containing small molecules as anti-inflammatory agents," which discloses methods for treating anti-inflammatory conditions through the use of these small molecules. The second patent, titled "Boron-containing small molecules as anti-protozoal agents," presents novel compounds that are useful in the treatment of protozoal infections. This invention also covers pharmaceutical compositions featuring these compounds, alongside combinations with additional therapeutically effective agents.

Career Highlights

Huchen Zhou is currently affiliated with Anacor Pharmaceuticals, Inc., where he actively contributes to the advancement of medicinal chemistry. His career is marked by a commitment to innovation and a focus on addressing unmet medical needs through his research and patents.

Collaborations

Throughout his career, Huchen Zhou has collaborated with esteemed colleagues such as Jacob J. Plattner and Yong-Kang Zhang. These partnerships have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of his inventions on the pharmaceutical landscape.

Conclusion

In conclusion, Huchen Zhou stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing boron-containing compounds for critical health challenges. His work at Anacor Pharmaceuticals, supported by his collaborative efforts, continues to pave the way for innovative solutions in anti-inflammatory and anti-protozoal treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…